Although normally dormant, hair follicle stem cells (HFSCs) quickly become activated to divide during a new hair cycle. The quiescence of HFSCs is known to be regulated by a number of intrinsic and extrinsic mechanisms. Here we provide several lines of evidence to demonstrate that HFSCs utilize glycolytic metabolism and produce significantly more lactate than other cells in the epidermis. Furthermore, lactate generation appears to be critical for the activation of HFSCs as deletion of lactate dehydrogenase (Ldha) prevented their activation. Conversely, genetically promoting lactate production in HFSCs through mitochondrial pyruvate carrier 1 (Mpc1) deletion accelerated their activation and the hair cycle. Finally, we identify small molecules that increase lactate production by stimulating Myc levels or inhibiting Mpc1 carrier activity and can topically induce the hair cycle. These data suggest that HFSCs maintain a metabolic state that allows them to remain dormant and yet quickly respond to appropriate proliferative stimuli.
The hair follicle is able to undergo cyclical rounds of rest (telogen), regeneration (anagen) and degeneration (catagen). The ability of the hair follicle to maintain this cycle depends on the presence of the hair follicle stem cells, which reside in the bulge (Fig. 1 ). At the start of anagen, bulge stem cells are activated by signals received from the dermal papilla, which at that stage abuts the bulge area 1, 2 . These stem cells exit the bulge and proliferate downwards, creating a trail that becomes the outer root sheath. Bulge stem cells are capable of giving rise to all the different cell types of the hair follicle. The ability of HFSCs to maintain quiescence and yet become proliferative for a couple days before returning to quiescence is unique in this tissue, and the precise mechanism by which these cells are endowed with this ability is not fully understood. While significant effort has produced a wealth of knowledge on both the transcriptional and epigenetic mechanisms by which HFSCs are maintained and give rise to various lineages 3, 4 , little is known about metabolic pathways in the hair follicle or adult stem cells in vivo.
Considering the fact that there are essentially no published data on metabolic states of any cell in the hair follicle, a detailed study of metabolism was necessary to understand the nature of HFSCs and their progeny. Several previous studies employed genetic disruption of the mitochondrial electron transport chain in the epidermis by deletion under the control of a pan-epidermal keratin promoter and found that mitochondrial function was essential for maintenance of the follicle [5] [6] [7] [8] . However, these studies did not explore the metabolic requirements for specific cell types within the tissue, nor did they explore a role for glycolytic metabolism. In this study, we present methods to study the metabolism of HFSCs in vivo, and provide evidence that these cells take advantage of a distinct mode of metabolism not found in their progeny. In the process, we also define small molecules that can take advantage of the unique metabolism of HFSCs to ignite the hair cycle in otherwise quiescent follicles.
RESULTS
Numerous studies have uncovered unique gene expression signatures in HFSCs versus other follicle cells or cells of the interfollicular epidermis [9] [10] [11] [12] . Many of these signatures are regulated by transcription factors that were later shown to play important roles in HFSC Figure 1 Lactate dehydrogenase activity is enriched in HFSCs. (a) IHC staining for Ldha expression across the hair cycle shows Ldha protein confined to the HFSC niche, the bulge, indicated by the bracket. IHC staining for Sox9 on serial sections demarcates the HFSC population. Scale bars, 20 µm. (b) Immunoblotting on FACS-isolated HFSC populations (α6low/Cd34 + and α6hi/Cd34 + ) versus total epidermis (Epi) shows differential expression of Ldha in the stem cell niche. Sox9 is a marker of HFSCs, and β-actin is a loading control. (c) Colorimetric assay for Ldh enzyme activity in the epidermis shows highest activity in the bulge (brackets) and subcuticular muscle layer (bracket). This activity is enriched in the bulge across different stages of the hair cycle. Activity is indicated by purple colour; pink is a nuclear counterstain. Note also that developing hair shafts in pigmented mice show strong deposits of melanin as observed here; hair shafts never displayed any purple stain indicative of Ldh activity. Scale bars, 50 µm. (d) Ldh activity in sorted cell populations, measured using a plate-readerbased assay, also shows the highest Ldh activity in two separate HFSC populations (α6hi/Cd34 + and α6low/Cd34 + ) compared with epidermal cells (Epi) and fibroblasts (FBs). Each bar represents the average signal for each cell type where n = 9 mice pooled from 3 independent experiments. Shown as mean ± s.e.m. Paired t-test was performed, P < 0.05 shown for each cell type versus epidermal cells. (e) HFSCs and epidermal cells were isolated during telogen (day 50) by FACS, and metabolites were extracted and analysed by LC-MS. Heatmaps show relative levels of glycolytic and TCA cycle metabolites from cells isolated from different mice in independent experiments with cells from three animals in each. G6P-F6P, glucose-6phosphate and fructose-6-phosphate; FBP, fructose-bisphosphate; DHAP, dihydroxyacetone phosphate; 3PG, 3-phosphoglycerate; and αKG, alphaketoglutarate. Asterisks indicate significant difference in metabolite levels between epidermal cells and HFSCs. For (e) paired t-test was performed; * P < 0.05; * * P < 0.01; * * * P < 0.001; NS, P > 0.05; n = 9 mice pooled from 3 independent experiments. Unprocessed original scans of blots are shown in Supplementary Fig. 6 .
homeostasis 13 . Lactate dehydrogenase is most commonly encoded by the Ldha and Ldhb genes in mammals, the protein products of which form homo-or hetero-tetramers to catalyse the NADH-dependent reduction of pyruvate to lactate and NAD + -dependent oxidation of lactate to pyruvate 14 . By immunostaining, Ldha appeared to be enriched in quiescent HFSCs in situ (telogen) (Fig. 1a ), and immunohistochemistry (IHC) with an antibody that recognizes both Ldha and Ldhb showed that only Ldha appears to be localized to the HFSC niche ( Supplementary Fig. 1a ).
HFSCs are known to go through successive rounds of quiescence (telogen) punctuated by brief periods of proliferation correlating with the start of the hair cycle (telogen-anagen transition) 4, 15 . Proliferation or activation of HFSCs is well known to be a prerequisite for advancement of the hair cycle. IHC analysis also showed that Ldha expression was enriched in HFSCs (Sox9 + ) at three stages of the hair cycle ( Fig. 1a ). Consistently, immunoblotting of lysates from sorted cells showed strong expression of Ldha in the basal HFSCs (α6hi/CD34 + ), and suprabasal (α6lo/CD34 + ) HFSC populations relative to total epidermis ( Fig. 1b) 9 (the sorting strategy is outlined in Supplementary Fig. 1b ).
To determine whether Ldha expression patterns correlate with activity of the Ldh enzyme, we used a colorimetric-based enzymatic assay to assess Ldh activity capacity in situ. Typically performed on protein lysates or aliquots with a plate reader 16 , we adapted the Ldh activity assay to work in situ on frozen tissue sections. Note that since both the in situ and in vitro Ldh activity assays employ use of excess substrate (lactate), the results from these assays reflect the capacity for Ldh activity, and not the steady-state activity.
Applying this assay to skin samples demonstrated that Ldh activity capacity was significantly higher in HFSCs, consistent with the expression pattern of Ldha ( Fig. 1c ). Furthermore, Ldh activity was enriched in HFSCs across the hair cycle ( Fig. 1c ). As a control, assays conducted without the enzymatic substrate (lactate) or on acidtreated tissue yielded zero activity ( Supplementary Fig. 1c ). To further validate these results, we sorted epidermal populations, generated cell lysates on the sorted cells, and performed a similar colorimetricbased enzymatic assay on the sorted cell lysates, which also showed increased Ldh activity in HFSCs ( Fig. 1d ). To better characterize the metabolism of HFSCs, we performed metabolomics analysis on sorted populations from mouse skin by liquid chromatography-mass spectrometry (LC-MS) ( Fig. 1e ). Several glycolytic metabolites, including glucose/fructose-6-phosphate, fructose-bisphosphate, dihydroxyacetone phosphate, 3-phosphoglycerate and lactate, were routinely higher in HFSCs relative to total epidermis across three independent experiments (isolated from different mice on different days). Conversely, most TCA cycle metabolites were not consistently different between the epidermis and HFSCs (Fig. 1e ). Collectively these results suggest that while all cells in the epidermis use the TCA cycle extensively to generate energy, HFSCs also have increased Ldha expression, Ldh activity and glycolytic metabolism.
Measuring metabolism across the hair cycle therefore would capture any dynamic changes that occur in HFSCs that correlate with activation or quiescence. Analysis of RNA-seq data from HFSCs isolated during either telogen or the telogen-anagen transition demonstrated not only that Ldha is the predominant Ldh isoform expressed in HFSCs ( Fig. 2c ), but it is also induced during the telogen-anagen transition ( Fig. 2a,b ) (NIHGEOGSE67404 and GSE51635). To confirm that the cells analysed by RNA-seq were indeed either in telogen or the telogen-anagen transition, important markers of this transition were assessed including the Shh and Wnt pathways (Gli1, 2, 3; Lef1, Axin1, Axin2 and Ccnd1) as well as proliferation markers (Ki-67, Pcna and Sox4) ( Supplementary Fig. 2a ).
The in vitro Ldh activity assay on lysates from sorted HFSCs uncovered a modest induction of Ldh activity correlating with the telogen-anagen transition ( Fig. 2d ). Hair cycle staging was validated by Ki-67 immunostaining to determine HFSC activation ( Supplementary Fig. 2b ). Additionally, measurements of steady-state metabolites extracted from sorted HFSCs showed an increase in lactate in HFSCs as they enter the telogen-anagen transition, and then decrease again in anagen as HFSCs return to quiescence ( Fig. 2e ).
To determine whether Ldh activity is functionally related to the ability of HFSCs to remain quiescent or to activate at the start of a hair cycle, we deleted Ldha specifically in the HFSCs. Taking advantage of mice with floxed alleles of Ldha 17 , this enzyme was deleted in HFSCs by crossing to mice bearing the K15-CrePR allele 11 , known to be inducible by mifepristone specifically in HFSCs. Deletion of Ldha in HFSCs was initiated by administration of mifepristone during telogen (day 50) and led to a typically mosaic recombination of the floxed alleles across the backskin 11, 18 . Mice with HFSC-specific deletion of Ldha failed to undergo a proper hair cycle, with most follicles remaining in telogen across at least 33 pairs of littermates 3-4 weeks after mifepristone treatment ( Fig. 3a) . A complete list of transgenic animals including birth date, sex and genotype is provided in Supplementary Table 1 .
Histology showed that wild-type hair follicles entered into the telogen-anagen transition typically by day 70, and this was accompanied by typical expansion of the hypodermis below ( Fig. 3b ). However, in backskin with deletion of Ldha, the hypodermis did not expand, and the telogen-anagen transition was severely abrogated (Fig. 3b ). In areas of strong phenotypic penetrance, Ldh activity was severely abrogated in the HFSC compartment ( Fig. 3c ), demonstrating that the Ldha allele is critically important for Ldh activity in HFSCs and consistent with the fact that isoform a of Ldh is expressed at the highest level. Quantification of hair cycle progression across numerous animals indicated that most follicles lacking Ldha remained in telogen ( Fig. 3d ).
In addition, to confirm the phenotypes, we also deleted Ldha with an independent HFSC-specific Cre strategy. Lgr5-CreER has been used for lineage tracing in a variety of adult stem cell models, and has been shown to mark cells with high regenerative capacity, including HFSCs 19 . Lgr5-CreER;Ldha fl/fl mice, treated with tamoxifen at postnatal day 50 prior to a synchronized hair cycle, also failed to activate anagen across at least 20 littermate pairs ( Fig. 3g ). In situ Ldh assay and metabolomics confirmed the successful deletion of Ldha in these animals ( Fig. 3h ,i).
We also monitored the effect of loss of Ldha activity in K15 + cells over a six-month period and found that deletion of Ldha led to a mosaic, but permanent block of HFSC activation in some portions of the backskin ( Supplementary Fig. 3a ). These data confirm that Ldh activity is required for HFSC activation, and is not simply a marker of HFSCs. A closer look at these long-term Ldha deletions showed that Ldha-null HFSCs continued expressing typical markers, but lacked Ldh activity, and failed to initiate new hair cycles, while those follicles that escaped deletion continued to express Ldha and to cycle normally ( Supplementary Fig. 3b ,c).
After sorting HFSCs from animals with or without Ldha deletion, LC-MS-based metabolomics analysis demonstrated that lactate levels, as well as levels of other glycolytic metabolites, were strongly
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Total epidermis Telogenanagen  Telogen  Anagen  Telogen  Anagen   1  2  3  1  2  3  1  2  3  1  2  3  1  2  3  1 reduced in the absence of Ldha (Fig. 3e ), functional evidence that the targeting strategy was successful. The fact that glycolytic metabolites upstream of lactate were also suppressed suggests that HFSCs could be adapting their metabolism to account for the loss of Ldh activity. Immunostaining for markers of HFSC activation and proliferation indicated a failure of HFSC activation. Ki-67 and pS6 have been clearly demonstrated to be abundant in the HFSC niche at the start of the hair cycle 20 , and both of these markers were absent in Ldha-deleted backskin (Fig. 3f ). Immunostaining for Ldha also confirmed successful deletion of this protein, while staining for Sox9, a marker of HFSCs, indicated that these cells remained in their niche, but just failed to activate in the absence of Ldha (Fig. 3f ). Induction of the hair cycle is also thought to be regulated by signalling from the Shh, Wnt and Jak-Stat pathways. We assayed each of these by IHC in normal or Ldha-deletion follicles and found that in general these pathways were not activated in Ldha-null HFSCs that failed to enter a telogen-anagen transition ( Supplementary Fig. 3d ).
Telogenanagen
To determine whether induction of lactate production could affect HFSC activation or the hair cycle, we crossed K15-CrePR animals to those floxed for mitochondrial pyruvate carrier 1 (Mpc1) (K15-CrePR;Mpc1 fl/fl ). Mpc1, as a heterodimer with Mpc2, forms the mitochondrial pyruvate carrier MPC, a transporter on the inner mitochondrial membrane required for pyruvate entry into the mitochondria 21 . Loss of function of Mpc1 has been shown to drive lactate production through enhanced conversion of pyruvate to lactate by Ldh 22 .
In animals with Mpc1 deletion in HFSCs, we observed a strong acceleration of the ventral and dorsal hair cycles with all the typical features of a telogen-anagen transition (Fig. 4a ) (n = 12 littermate pairs). Mifepristone-treated K15-CrePR;Mpc1 fl/fl animals were the only ones to show any signs of dorsal anagen by day 70. Western blotting on sorted HFSCs validated the loss of Mpc1 protein (Fig. 4b) . Importantly, purified HFSCs lacking Mpc1 showed a strong induction of Ldh activity (Fig. 4c ). Quantification of the dorsal hair cycle across three pairs of littermates showed a strong induction of anagen in backskin lacking Mpc1 (Fig. 4d, right) , and histology showed that the anagen induction was normal in appearance with a typical hypodermal expansion (Fig. 4d) . Immunostaining demonstrated the induction in Mpc1-null HFSCs of various markers of hair cycle activation such as Ki-67 and pS6, while Sox9 expression was unaffected (Fig. 4e ). Long-term deletion of Mpc1 did not lead to aberrant follicles or exhaustion of HFSCs as judged by pathology and staining for Sox9 ( Supplementary  Fig. 4a ). Furthermore, deletion of Mpc1 with Lgr5-CreER showed a very similar phenotype as deletion with K15-CrePR (Fig. 4f,g) , validating the fact that deletion of this protein in HFSCs leads to their activation (n = 12 pairs of littermates). Finally, immunofluorescence for the Ires-GFP of the Lgr5-CreER transgene along with Ki-67 and lineage tracing with K15-CrePR;Mpc1 fl/fl ;lsl-Tomato mice also demonstrated that the HFSCs were indeed proliferative following induction of Mpc1 deletion by tamoxifen or mifepristone ( Supplementary Fig. 4b ).
On the other hand, deletion of Mpc1 in the top of the follicle (infundibulum, sebaceous gland progenitors) and a limited number of interfollicular cells with Lgr6-CreER (ref. 23 ) did not appear to affect the hair cycle (Lgr6-CreER;Mpc1 fl/fl ) (n = 10 littermate pairs) or general skin homeostasis over at least 2 months ( Supplementary  Fig. 4c ). Ldh activity assay on Lgr6 + cells sorted from wildtype or deletion skin demonstrated that the Mpc1 deletion was effective ( Supplementary Fig. 4d ). Together, these results indicate that increasing lactate production through the blockade of pyruvate into the TCA cycle has a strong effect on the ability of HFSCs, but not other cells in the hair follicle, to become activated to initiate a new hair cycle.
UK-5099 is a well-established pharmacological inhibitor of the mitochondrial pyruvate carrier and is known to promote lactate production as a result in various settings 24 . Topical treatment of animals in telogen (day 50) with UK-5099 led to a robust acceleration of the hair cycle, as well as minor hyperproliferation of the interfollicular epidermis (Fig. 5a ). Quantification of the hair cycle across at least 6 pairs of animals (vehicle versus UK-5099) indicated a strong acceleration of the hair cycle, in as few as 6-9 days (Fig. 5b ). Similar to genetic deletion of Mpc1, pharmacological blockade of the mitochondrial pyruvate carrier by UK-5099 for 48 h during telogen promoted increased Ldh activity in HFSCs and the interfollicular epidermis, consistent with increased capacity for lactate production (Fig. 5c ). Finally, metabolomic analysis demonstrated that topical application of UK-5099 increases total levels of lactate in sorted HFSCs (Fig. 5d ).
Because alteration of lactate production in HFSCs appeared to regulate their activation, we attempted to identify other small molecules that could take advantage of these findings to induce the hair cycle. Ldha is known to be transcriptionally regulated by Myc, which has been shown to play an important role in HFSC activation and the hair cycle [25] [26] [27] . RNA-seq on sorted HFSCs indicated that Myc is induced during the telogen-anagen transition (Fig. 6a ). Western blotting for both c-Myc and n-Myc in sorted HFSCs versus total epidermis showed a strong increase in Myc protein in the nuclei of HFSCs (Fig. 6b) .
Taking advantage of a molecule with the robust ability to promote Myc expression through binding of GP130 and activation of Jak/Stat signalling, we topically treated mice for 48 h to determine the effect of RCGD423 on Stat signalling and Myc expression. We found that RCGD423 induced levels of both c-Myc and n-Myc as well as Ldha (Fig. 6c) , consistent with activation of Stat3 signalling leading to induction of Myc and Ldha protein expression. In vitro measurement of Ldh activity on lysates from total epidermis showed an increase in activity by RCGD423 (Fig. 6d) . In situ staining for Ldh activity showed a strong induction following treatment with RCGD423 in both the epidermis and even in the dermis, as expected with topical treatment (Fig. 6e ). LC-MS-based metabolomics on epidermis isolated from vehicle or RCGD423 showed a large increase in lactate as well, even after just 48 h (Fig. 6f ).
RCGD423 binds to GP130, a co-receptor for Jak-Stat signalling, and activates Stat3. We found that Stat3 was activated in HFSCs by RCGD423 after topical treatment by immunostaining with phospho-Stat3 antibody (Fig. 6g ). This also correlated with induction of Ki-67 in HFSCs in the same tissue (Fig. 6g ). IHC for pStat1 and pStat5 suggested that RCGD423 does not dramatically affect these other Stat family members ( Supplementary Fig. 5 ). Topical treatment of animals in telogen (day 50) with RCGD423 led to a robust acceleration of the hair cycle (Fig. 6h) , as well as minor hyperproliferation of the interfollicular epidermis.
DISCUSSION
Together, these data demonstrate that the production of lactate, through Ldha, is important for HFSC activation, and that HFSCs may maintain a high capacity for glycolytic metabolism at least in part through the activity of Myc. Our data also demonstrate that a genetic or pharmacological disruption of lactate production can be exploited to regulate the activity of HFSCs. It is possible that these results have implications for adult stem cells in other tissues. In an accompanying manuscript, the Rutter laboratory describes a role for Mpc1 in adult intestinal stem cells 28 . Consistent with data presented here on HFSCs, deletion of Mpc1 led to an increase in the ability of intestinal stem cells to form organoids. Supplementary Fig. 6 . Previous work showed that haematopoietic stem cells (HSCs) show higher glycolytic activity, but disruption of glycolysis in the HSCs led to activation of their cycling [29] [30] [31] [32] , contrary to what we find with HFSCs. While the distinction could be biological, there are technical reasons for potential discrepancies as well. First, there are no Cre transgenic lines that can delete genes specifically in HSCs, as opposed to HFSCs (K15 + or Lgr5 + ). Second, to block glycolysis in HSCs, the previous study deleted the PDK enzyme, which would only indirectly regulate glycolysis, whereas here we deleted the Ldh enzyme specifically. In addition, HSCs and HFSCs are functionally distinct in that HFSCs cycle only at well-defined moments (telogen-anagen transition), while the timing of HSC activation is not as well established or synchronized. Instead, we hypothesize that increased glycolytic rate in HFSCs allows them to respond quickly to the barrage of cues that orchestrate the onset of a new hair cycle. This has also been proposed to be the case for neural stem cells solely on the basis of RNA-seq data 33 , but as of yet no in vivo functional evidence exists to confirm this possibility.
The fact that small molecules could be used to promote HFSC activation suggests that they could be useful for regenerative medicine. This is not only the case for hair growth, but potentially for wound healing as well. While HFSCs do not normally contribute to the interfollicular epidermis, in a wound setting, HFSCs migrate towards the wound site and make a contribution, as measured by lineage tracing 34 . Whether activation of Ldh enzyme activity by Mpc1 inhibition (UK-5099) or Myc activation (RCGD423) can promote wound healing will be the subject of intense effort going forward. Supplementary Fig. 6 .
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. For experiments that include analysis of the telogen stage of the hair cycle, animals were harvested at postnatal day 50, for telogen-anagen transition animals were harvested at day 70, and for anagen animals were harvested at postnatal day 90. For experiments that include analysis of transgenic animals, K15-CrePR animals were shaved and treated by injection of mifepristone and Lgr5-CreER and Lgr6-CreER animals were shaved and treated with tamoxifen (10 mg ml −1 dissolved in sunflower seed oil, 2 mg per day for 3 days) during telogen (postnatal day 50), and monitored for hair regrowth following shaving. For Figs 5 and 6 , wildtype C57BL/6J animals were shaved at postnatal day 50 and treated topically with Transderma Plo Gel Ultramax Base (TR220) (vehicle), UK-5099 (Sigma PZ0160) (20 µM) or RCGD423 (50 µM) for the indicated periods of time. Both male and female animals were used in this study in approximately equal numbers with no apparent difference in phenotype between genders. All animal experiments were performed in compliance with ethical guidelines and approved by the UCLA Animal Research Committee (ARC) according to IACUC guidelines in facilities run by the UCLA Department of Laboratory Animal Medicine (DLAM).
Histology, immunostaining and immunoblotting. Tissues were isolated from the indicated genotypes and embedded fresh in OCT compound for frozen tissue preparations, or fixed overnight in 4% formalin and embedded in paraffin. For frozen tissue, sectioning was performed on a Leica 3200 Cryostat, and the sections were fixed for 5 min in 4% paraformaldehyde. Paraffin-embedded tissue was sectioned, de-paraffinized and prepared for histology. All sections prepared for staining were blocked in staining buffer containing appropriate control IgG (goat, rabbit and so on). Immunohistochemistry was performed on formalin-fixed paraffin-embedded tissue with citrate or Tris buffer antigen retrieval with the following antibodies: Cell isolation and FACS. Whole dorsal and ventral mouse skin was excised and floated on trypsin (0.25%) for 1 h at 37 • or overnight at 4 • . The epidermis was separated from dermis by scraping and epidermal cells were mechanically dissociated using a pipette. Epidermal cells were filtered with a 70 µM cell strainer into 20% BCS, collected at 300g and washed twice with PBS. The cells were then filtered through a 40 µM cell strainer and stained for FACS processing with CD34 Monoclonal Antibody (RAM34), FITC, eBioscience (catalogue no. 11-0341-82) and CD49d (Integrin alpha 4) Monoclonal Antibody (R1-2), PE, eBioscience (catalogue no. 12-0492-81). The gating strategy is shown in Supplementary Fig. 1b . Cells were sorted using BD FACSAria high-speed cell sorters. Single-positive and doublepositive populations were collected into 20% BCS, RIPA lysis buffer (Thermo Scientific, Pierce), or 80% methanol for enzymatic assays, western blots or mass spectrometry analyses respectively.
